Co-Founder & CEO — AI HealthTech for Real-Time Compliance

The Opportunity

FutureSight is seeking a Co-Founder & CEO to lead Clairo, an AI-native clinical documentation compliance venture currently in build at our studio. This is a co-founder partnership with meaningful founder equity, not a salaried executive role.

Clairo AI audits 100% of healthcare charts in real-time, catches payer‑specific gaps before they hit billing, and eliminates the manual QA overhead that costs organizations millions in denials and clawbacks every year. Currently, manual QA teams consume 25%+ of operational labour budgets, yet audit only about 10% of patient charts, leaving organizations massively exposed.

Market Context

We didn't just build a thesis; we validated it directly with the market. We have spoken directly with Compliance Directors, QA Leaders, and Revenue Cycle Directors across behavioural health organizations. The market signal is incredibly strong:

• Unprompted Product Pull: Every single lead described the exact product we want to build: a pre‑billing, real‑time, EHR‑integrated flagging layer that checks documentation against payer‑specific rules before claims are submitted.
• Massive Financial Pain: The real pain comes from post‑payment recoupments (clawbacks). Buyers cited chronic, aggressive payer audits happening weekly or monthly, with single audit events causing catastrophic losses ranging from $150,000 to $850,000.
• Budget is NOT the Blocker: Buyers explicitly stated that if the tool integrates cleanly with their EHR and meets a high accuracy bar, securing the budget is not a problem.

We are targeting a large, highly fragmented market where revenue cycle teams are increasingly struggling to manage denials at scale. The total addressable market is estimated at $4.0B–$6.0B+, spanning more than 20,000 organizations, including multispecialty groups, behavioural health providers, and health systems. The ROI case is compelling: at current price points, the software can quickly pay for itself by reducing manual auditing labour by an estimated 80–85% while also preventing clawbacks that translate into millions in avoided losses.

About FutureSight

FutureSight is a leading venture studio that co‑creates world‑class software companies with values‑driven entrepreneurs from inception to exit. We are a team of founders, operators and designers with experience successfully bringing software to market at scale.

You’ll co‑create with a proven studio team, including:

• John Carbrey – 4x founder, bootstrapped to $100M ARR
• Joshua Auslander – Seasoned CFO and strategic advisor with $200M aggregate exits
• Alan Smith – Globally recognized early stage validation expert, 24 products launched, an exit, 5M+ books sold
• Prathna Ramesh – Early‑stage investor and capital strategy advisor

The Partnership

• Founder equity with meaningful ownership from inception
• Pre‑seed capital committed by FutureSight for early hires and MVP development, with potential for follow‑on funding
• Studio resources, including embedded design, engineering, growth, and fundraising support from day one
• Investor and advisor network across healthtech and early‑stage capital markets
• A true co‑creation model in which you operate as CEO with the studio as your partner

What You’ll Own

As Co‑Founder & CEO, you will set the venture's direction and lead its execution.

• Strategy — Refine the ICP, pricing model, and product positioning
• Customer Development — Lead pilots with compliance and revenue cycle leaders, convert them to paid engagements, and build the go‑to‑market motion
• Product — Partner with the FutureSight product and engineering team to ship V1 and iterate on user feedback
• Capital — Lead the seed raise, supported by FutureSight's network and tractionTeam — Recruit and lead the founding team, and establish the cultural foundation of the company

Co‑Founder Profile

• Previous founding experience at a venture‑backed company
• Demonstrated success in B2B SaaS go‑to‑market, including sales and customer engagement
• Fundraising fluency, with the ability to develop investor narratives and close capital
• Proven ability to attract, develop, and retain top talent
• Clear‑eyed understanding of the risks and demands of co‑founding a venture‑backed company
• RCM Domain & Workflow Depth: Deep, operational exposure to healthcare revenue cycle, medical billing, or denial management. You must intuitively understand the operational differences between clinical/coding denials and administrative roadblocks. You are familiar with the fragmented realities of smaller EHR/PM systems and the "band‑aid" tech stacks billers use to survive

FutureSight is committed to diversity, equity, and inclusion. We welcome applicants of all backgrounds and experiences.